EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›TCNNF

TCNNF

Trulieve Cannabis Corp.

Next earnings Aug 4, 2026 · consensus $0.04 EPS, $297M rev

Last earnings -4.9% on 2026-05-07

Avoid
$8.99
▲ +5.52%
$8.99▲ +174.92%
over 1Y
L $3.27EODHDH $13.00
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.5%
1W-11.0%
1M+6.5%
3M+71.9%
YTD+3.3%
1Y+174.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
C-
Valuation
Fair value
Filings
Watch
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy

Revenue declined -0.4% YoY.

Revenue (FY2025) $1.18B · FY2025

Trulieve Cannabis Corp. shows $1.18B in FY2025 revenue (-0.4% YoY), a -10.3% net margin, and -10.7% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$932M$1.22B$1.13B$1.19B$1.18B
Gross profit$567M$689M$589M$716M$711M
Operating income$204M$50.2M-$222M$97.8M$143M
Net income$17.4M-$253M-$533M-$161M-$122M
Diluted EPS$0.21-$0.95-$2.28-$0.79-$0.58
Net margin1.9%-20.7%-47.2%-13.5%-10.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)8.9%
Free cash flow$229M
Total debt$137M
Net cash$119M
Piotroski F-Score6/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. DEF 14A Proxy statement2026-06-25
  2. 8-K Officer / director change2026-06-12
  3. 8-K Shareholder vote2026-06-11
  4. 8-K Other event2026-06-09
  5. 8-K Material agreement2026-06-04
  6. 8-K Earnings results2026-05-07
  7. 10-Q Quarterly report2026-05-07
  8. DEF 14A Proxy statement2026-04-29
  9. 8-K Officer / director change2026-04-21

Recent filings

all on EDGAR ↗
4Period ending 2026-06-262026-06-26open ↗4Period ending 2026-06-232026-06-25open ↗DEF 14APeriod ending 2026-06-252026-06-25open ↗DEFA14AFiling2026-06-25open ↗4Period ending 2026-06-172026-06-22open ↗144Filing2026-06-17open ↗PRE 14APeriod ending 2026-06-082026-06-12open ↗8-KPeriod ending 2026-06-112026-06-12open ↗8-KPeriod ending 2026-06-092026-06-11open ↗CERTFiling2026-06-09open ↗8-KPeriod ending 2026-06-092026-06-09open ↗8-A12BFiling2026-06-09open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
Value—
GrowthC+
ProfitabilityD
Financial healthC+
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$1.18B
-0.4% YoY
Net margin
-10.3%
ROE
-10.7%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.18B-0.4%
Net income-$122M+23.9%
Gross profit$711M-0.6%
Operating income$143M+46.8%
Diluted EPS-$0.58+26.6%
Cash & equivalents$256M+7.0%
Total assets$2.70B-6.1%
Total liabilities$1.55B-4.2%
Stockholders' equity$1.14B-8.5%
Gross: 60.2%Op.: 12.1%L/E: 1.36x

Frequently asked

Is Trulieve Cannabis Corp. (TCNNF) a buy?
TCNNF currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue declined -0.4% YoY.
What is Trulieve Cannabis Corp.'s quality score?
TCNNF scores 52.8974358974359/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001754195, latest 10-Q filed 2026-05-07) · EODHD · as of 6/28/2026, 4:39:54 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 7 sales

2026-06-26
Rivers Kim A.
Chairman and CEO
Sell137K @ $8.76$1.20M
2026-06-25
Rivers Kim A.
Chairman and CEO
Sell300K @ $8.17$2.45M
2026-06-24
Rivers Kim A.
Chairman and CEO
Sell400K @ $8.17$3.27M
2026-06-23
Rivers Kim A.
Chairman and CEO
Sell380K @ $8.47$3.22M
2026-06-22
Rivers Kim A.
Chairman and CEO
Sell205K @ $9.35$1.92M
2026-06-18
Rivers Kim A.
Chairman and CEO
Sell140K @ $9.46$1.32M
2026-06-17
Rivers Kim A.
Chairman and CEO
Sell138K @ $9.36$1.29M
2026-03-13
Rivers Kim A.
Chairman and CEO
Award219K
2026-03-13
Pernell Jason
President
Award58.6K
2026-03-13
Hersey Christine Ann
Chief Corp Affairs & Strategy
Award58.6K
2026-03-13
Landrum Kyle
Chief Production Officer
Award58.6K
2026-03-13
Reese Jan
Chief Financial Officer
Award58.6K

Earnings history

beat/miss · move
2026-05-07Beat +165.4% est▼ -4.90%8-K ↗
2026-02-26Miss -866.4% est▲ +1.56%8-K ↗
2025-11-05Miss -52.5% est▲ +2.27%8-K ↗
2025-08-06Miss -5.6% est▼ -4.86%8-K ↗
2025-05-07—▼ -2.46%8-K ↗
2025-02-27—▲ +5.52%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 sell · 1 member · last 180d

−$32.5K net soldlast trade 53d ago
$0.00 bought$32.5K sold
2026-05-07Greg StantonSell$15.0K–$50.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Trulieve Will Become the First U.S. Cannabis Company to List on the NYSEBullish
finance.yahoo.com· 2026-06-05
Cannabis Stocks Are Heating Up Again. Here's Which Ones Could be the Biggest Winners.Bullish
finance.yahoo.com· 2026-06-01
State AGs challenge Trump admin medical marijuana shiftBullish
seekingalpha.com· 2026-05-28
Trulieve anticipates at least $250M 2026 operating cash flow while exploring U.S. exchange uplistingBullish
seekingalpha.com· 2026-05-08
2 Medical Marijuana Stocks to Buy NowBullish
finance.yahoo.com· 2026-05-03
3 Cannabis Stocks That Could Soar After Marijuana ReschedulingBullish
finance.yahoo.com· 2026-04-28

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score53 vs 67
Revenue growth-0.4% vs 7.1%
Net margin-10.3% vs 10.5%
Return on equity-10.7% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 5d
Bullish
+0.17
vs typical · 5 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.